Literature DB >> 6998615

Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus.

J M Kilpatrick, G Virella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6998615      PMCID： PMC1538931     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  8 in total

1.  Isolation of soluble immune complexes by affinity chromatography using staphylococcal protein A--Sepharose as substrate.

Authors:  F Chenais; G Virella; C C Patrick; H H Fudenberg
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

2.  Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol.

Authors:  M Digeon; M Laver; J Riza; J F Bach
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

3.  Measurement of immune complexes in insulin-treated diabetics.

Authors:  K S Jayarao; W P Faulk; J H Karam; G M Grodsky; P H Forsham
Journal:  J Immunol Methods       Date:  1973-12       Impact factor: 2.303

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  Use of laser nephelometry in the measurement of serum proteins.

Authors:  C D Deaton; K W Maxwell; R S Smith; R L Creveling
Journal:  Clin Chem       Date:  1976-09       Impact factor: 8.327

6.  Method for rapid quantitation and characterization of insulin antibodies.

Authors:  K D Gerbitz; W Kemmler
Journal:  Clin Chem       Date:  1978-06       Impact factor: 8.327

7.  Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.

Authors:  W J Irvine; S F Al-Khateeb; U Di Mario; C M Feek; R S Gray; B Edmond; L J Duncan
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

8.  Nephelometric detection of soluble immune complexes: methodology and clinical applications.

Authors:  G Virella; W A Hipp; J F John; B Kahaleh; M Ford; H H Fudenberg
Journal:  Int Arch Allergy Appl Immunol       Date:  1979
  8 in total
  10 in total

Review 1.  Insulin antibody determination: theoretical and practical considerations.

Authors:  W G Reeves
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

2.  Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance.

Authors:  G Virella; H Wohltmann; J Sagel; M F Lopes-Virella; M Kilpatrick; C Phillips; J Colwell
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

3.  Does insulin administration contribute to immune complex formation in diabetes?

Authors:  L V Campbell; J A Charlesworth; G V Pasterfield; A Jenkins; B A Pussell
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

4.  Evaluation of the presence of circulating immune complexes and their relationship to glomerular IgG deposits in streptozotocin-induced diabetic rats.

Authors:  C K Abrass
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  The role of circulating immune complexes in the pathogenesis of diabetes mellitus.

Authors:  J M Kilpatrick; G Virella
Journal:  Acta Diabetol Lat       Date:  1982 Apr-Jun

6.  Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats.

Authors:  R F Dons; R Havlik; S I Taylor; K L Baird; S S Chernick; P Gorden
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

7.  Isolation and characterization of circulating immune complexes in cystic fibrosis.

Authors:  R B Moss; Y P Hsu
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

8.  Circulating immune complexes in patients with diabetes mellitus.

Authors:  C K Abrass; D Heber; J Lieberman
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

9.  The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.

Authors:  U Di Mario; D Q Borsey; G Contreas; C V Prowse; B F Clarke; D Andreani
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

10.  Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis.

Authors:  Fauzia Jamal; Pushkar Shivam; Sarita Kumari; Manish Kumar Singh; Abul Hasan Sardar; Selvasankar Murugesan; Shyam Narayan; Anil Kumar Gupta; Krishna Pandey; V N R Das; Vahab Ali; Sanjiva Bimal; Pradeep Das; Shubhankar K Singh
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.